Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials.
Heng, D Y C
Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Jan 2014 - 149-54 p. digital
Publication Type: Journal Article
1569-8041
10.1093/annonc/mdt492 doi
Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bevacizumab
Brain Neoplasms--drug therapy
Carcinoma, Renal Cell--drug therapy
Clinical Trials as Topic
Disease-Free Survival
Eligibility Determination
Humans
Indazoles
Indoles--administration & dosage
Kaplan-Meier Estimate
Karnofsky Performance Status
Kidney Neoplasms--drug therapy
Middle Aged
Molecular Targeted Therapy
Niacinamide--administration & dosage
Phenylurea Compounds--administration & dosage
Pyrimidines--administration & dosage
Pyrroles--administration & dosage
Sorafenib
Sulfonamides--administration & dosage
Sunitinib
Treatment Outcome
Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Jan 2014 - 149-54 p. digital
Publication Type: Journal Article
1569-8041
10.1093/annonc/mdt492 doi
Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bevacizumab
Brain Neoplasms--drug therapy
Carcinoma, Renal Cell--drug therapy
Clinical Trials as Topic
Disease-Free Survival
Eligibility Determination
Humans
Indazoles
Indoles--administration & dosage
Kaplan-Meier Estimate
Karnofsky Performance Status
Kidney Neoplasms--drug therapy
Middle Aged
Molecular Targeted Therapy
Niacinamide--administration & dosage
Phenylurea Compounds--administration & dosage
Pyrimidines--administration & dosage
Pyrroles--administration & dosage
Sorafenib
Sulfonamides--administration & dosage
Sunitinib
Treatment Outcome